|
1
|
Vogelstein B, Lane D and Levine AJ:
Surfing the p53 network. Nature. 408:307–310. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kastan MB and Berkovich E: p53: a
two-faced cancer gene. Nat Cell Biol. 9:489–491. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bossi G, Marampon F, Maor-Aloni R, Zani B,
Rotter V, Oren M, Strano S, Blandino G and Sacchi A: Conditional
RNA interference in vivo to study mutant p53 oncogenic gain of
function on tumor malignancy. Cell Cycle. 7:1870–1879. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Adorno M, Cordenonsi M, Montagner M,
Dupont S, Wong C, Hann B, Solari A, Bobisse S, Rondina MB, Guzzardo
V, et al: A Mutant-p53/Smad complex opposes p63 to empower
TGFbeta-induced metastasis. Cell. 137:87–98. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lukashchuk N and Vousden KH:
Ubiquitination and degradation of mutant p53. Mol Cell Biol.
27:8284–8295. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Muller P, Hrstka R, Coomber D, Lane DP and
Vojtesek B: Chaperone-dependent stabilization and degradation of
p53 mutants. Oncogene. 27:3371–3383. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Olive KP, Tuveson DA, Ruhe ZC, Yin B,
Willis NA, Bronson RT, Crowley D and Jacks T: Mutant p53 gain of
function in two mouse models of Li-Fraumeni syndrome. Cell.
119:847–860. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Y, Guessous F, Kwon S, Kumar M, Ibidapo
O, Fuller L, Johnson E, Lal B, Hussaini I, Bao Y, et al: PTEN has
tumor-promoting properties in the setting of gain-of-function p53
mutations. Cancer Res. 68:1723–1731. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin K, Rockliffe N, Johnson GG,
Sherrington PD and Pettitt AR: Hsp90 inhibition has opposing
effects on wild-type and mutant p53 and induces p21 expression and
cytotoxicity irrespective of p53/ATM status in chronic lymphocytic
leukaemia cells. Oncogene. 27:2445–2455. 2008. View Article : Google Scholar
|
|
10
|
Zou M, Al-Baradie RS, Al-Hindi H, Farid NR
and Shi Y: S100A4 (Mts1) gene overexpression is associated with
invasion and metastasis of papillary thyroid carcinoma. Br J
Cancer. 93:1277–1284. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cho YG, Nam SW, Kim TY, Kim YS, Kim CJ,
Park JY, Lee JH, Kim HS, Lee JW, Park CH, et al: Overexpression of
S100A4 is closely related to the aggressiveness of gastric cancer.
APMIS. 111:539–545. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matsumoto K, Irie A, Satoh T, Ishii J,
Iwabuchi K, Iwamura M, Egawa S and Baba S: Expression of S100A2 and
S100A4 predicts for disease progression and patient survival in
bladder cancer. Urology. 70:602–607. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Grigorian M, Andresen S, Tulchinsky E,
Kriajevska M, Carlberg C, Kruse C, Cohn M, Ambartsumian N,
Christensen A, Selivanova G, et al: Tumor suppressor p53 protein is
a new target for the metastasis-associated Mts1/S100A4 protein:
Functional consequences of their interaction. J Biol Chem.
276:22699–22708. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yamada Y, Yoshida T, Hayashi K, Sekiya T,
Yokota J, Hirohashi S, Nakatani K, Nakano H, Sugimura T and Terada
M: p53 gene mutations in gastric cancer metastases and in gastric
cancer cell lines derived from metastases. Cancer Res.
51:5800–5805. 1991.PubMed/NCBI
|
|
15
|
Hua J, Chen D, Fu H, Zhang R, Shen W, Liu
S, Sun K and Sun X: Short hairpin RNA-mediated inhibition of S100A4
promotes apoptosis and suppresses proliferation of BGC823 gastric
cancer cells in vitro and in vivo. Cancer Lett. 292:41–47. 2010.
View Article : Google Scholar
|
|
16
|
Yan W, Liu G, Scoumanne A and Chen X:
Suppression of inhibitor of differentiation 2, a target of mutant
p53, is required for gain-of-function mutations. Cancer Res.
68:6789–6796. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mizushima N, Yamamoto A, Matsui M,
Yoshimori T and Ohsumi Y: In vivo analysis of autophagy in response
to nutrient starvation using transgenic mice expressing a
fluorescent autophagosome marker. Mol Biol Cell. 15:1101–1111.
2004. View Article : Google Scholar :
|
|
18
|
Kanzawa T, Zhang L, Xiao L, Germano IM,
Kondo Y and Kondo S: Arsenic trioxide induces autophagic cell death
in malignant glioma cells by upregulation of mitochondrial cell
death protein BNIP3. Oncogene. 24:980–991. 2005. View Article : Google Scholar
|
|
19
|
Frazier MW, He X, Wang J, Gu Z, Cleveland
JL and Zambetti GP: Activation of c-myc gene expression by
tumor-derived p53 mutants requires a discrete C-terminal domain.
Mol Cell Biol. 18:3735–3743. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Morselli E, Tasdemir E, Maiuri MC,
Galluzzi L, Kepp O, Criollo A, Vicencio JM, Soussi T and Kroemer G:
Mutant p53 protein localized in the cytoplasm inhibits autophagy.
Cell Cycle. 7:3056–3061. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vaqué JP, Fernández-García B, García-Sanz
P, Ferrandiz N, Bretones G, Calvo F, Crespo P, Marín MC and León J:
c-Myc inhibits Ras-mediated differentiation of pheochromocytoma
cells by blocking c-Jun up-regulation. Mol Cancer Res. 6:325–339.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Watanabe H, Tokuyama H, Ohta H, Satomura
Y, Okai T, Ooi A, Mai M and Sawabu N: Expression of placental
alkaline phosphatase in gastric and colorectal cancers. An
immunohistochemical study using the prepared monoclonal antibody.
Cancer. 66:2575–2582. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
van Dieck J, Teufel DP, Jaulent AM,
Fernandez-Fernandez MR, Rutherford TJ, Wyslouch-Cieszynska A and
Fersht AR: Posttranslational modifications affect the interaction
of S100 proteins with tumor suppressor p53. J Mol Biol.
394:922–930. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
van Dieck J, Fernandez-Fernandez MR,
Veprintsev DB and Fersht AR: Modulation of the oligomerization
state of p53 by differential binding of proteins of the S100 family
to p53 monomers and tetramers. J Biol Chem. 284:13804–13811. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fernandez-Fernandez MR, Veprintsev DB and
Fersht AR: Proteins of the S100 family regulate the oligomerization
of p53 tumor suppressor. Proc Natl Acad Sci USA. 102:4735–4740.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Orre LM, Panizza E, Kaminskyy VO, Vernet
E, Gräslund T, Zhivotovsky B and Lehtiö J: S100A4 interacts with
p53 in the nucleus and promotes p53 degradation. Oncogene.
32:5531–5540. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Berge G, Costea DE, Berg M, Rasmussen H,
Grotterød I, Lothe RA, Mælandsmo GM and Flatmark K: Coexpression
and nuclear colocalization of metastasis-promoting protein S100A4
and p53 without mutual regulation in colorectal carcinoma. Amino
Acids. 41:875–884. 2011. View Article : Google Scholar
|
|
28
|
Scian MJ, Stagliano KE, Anderson MA,
Hassan S, Bowman M, Miles MF, Deb SP and Deb S: Tumor-derived p53
mutants induce NF-kappaB2 gene expression. Mol Cell Biol.
25:10097–10110. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zalcenstein A, Stambolsky P, Weisz L,
Müller M, Wallach D, Goncharov TM, Krammer PH, Rotter V and Oren M:
Mutant p53 gain of function: Repression of CD95 (Fas/APO-1) gene
expression by tumor-associated p53 mutants. Oncogene. 22:5667–5676.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rosty C, Ueki T, Argani P, Jansen M, Yeo
CJ, Cameron JL, Hruban RH and Goggins M: Overexpression of S100A4
in pancreatic ductal adenocarcinomas is associated with poor
differentiation and DNA hypomethylation. Am J Pathol. 160:45–50.
2002. View Article : Google Scholar : PubMed/NCBI
|
